Contract Services Contract Research
Naobios and Tokyo Metropolitan Institute of Medical Science Partner to Develop Next-Generation Mpox Vaccine
Naobios, a CDMO providing bioprocess development and GMP production of clinical batches of virus-based products, and the Tokyo Metropolitan Institute of Me...
October 27, 2025 | News
Syngene Strengthens India’s ADC Ecosystem With New GMP Bioconjugation Suite in Bengaluru
Syngene International, a global contract research, development and manufacturing organization (CRDMO), is adding a GMP bioconjugation suite at its commerci...
October 24, 2025 | News
SunRock Biopharma and Chime Biologics Partner to Advance Novel Anti-CCR9 Antibody Therapy for Inflammatory Bowel Disease
SunRock Biopharma, a biotechnology company focused on developing next-generation therapeutic antibodies, and Chime Biologics, a global leading contrac...
October 22, 2025 | News
AstraZeneca Invests $445 Million to Expand Texas Manufacturing Hub in the United States, Doubling Global Lokelma Production
AstraZeneca announces the unveiling of its newly-expanded, state-of-the-art manufacturing facility in Coppell, Texas. The expansion project will double the...
October 16, 2025 | News
Teijin and Cell Therapies Forge a Cross-Border Alliance to Accelerate Cell and Gene Therapy Access Between Japan and Australia
As the cell and gene therapy (CGT) sector moves from scientific promise to large-scale reality, collaboration between nations with strong translational and...
October 06, 2025 | News | By arcilla.fran@biopharmaapac.com
Catalent Opens New Global Headquarters in Tampa to Shape the Future of Biopharma Innovation
Relocation reflects a strategic expansion in Florida alongside long-standing manufacturing facility in nearby St. Petersburg New ...
September 29, 2025 | News
Avance Clinical Guides 710 Emerging Biotechs Through Critical Early-Phase Milestones
Avance Clinical, a partner for biotechs providing global contract research organization services, has now guided 710 emerging biotechs through critical cli...
August 28, 2025 | News
GenScript Biotech CEO Sherry Shao Champions Innovation and Global Expansion as H1 2025 Profits Surge Over 500%
GenScript Biotech Corporation (HK.1548), a global pioneer in life sciences innovation, today announced outstanding interim results for the first half of 20...
August 18, 2025 | Company results
PolyActiva Launches U.S. Trial of Glaucoma Implant Following Australia Success
PA5108, a new chemical entity, is an investigational, biodegradable ocular micro implant, designed to deliver sustained intraocular pressure control for ...
August 08, 2025 | News
Tigermed Acquires Japan’s First Imaging CRO Micron to Bolster Asia-Pacific Medical Imaging Capabilities
Tigermed, a leading global provider of clinical research solutions across the full lifecycle of global biopharmaceutical and medical device products, annou...
July 30, 2025 | News
WuXi AppTec Issues Positive Profit Alert with Over 100% Surge in H1 2025 Net Profit
WuXi AppTec Co., Ltd., a leading global pharmaceutical and life sciences technology platform company offering integrated, end-to-end new drug R&D and m...
July 11, 2025 | News
WuXi AppTec Completes RMB1 Billion A-Share Buyback and HKD2.5 Billion H-Share Acquisition to Drive Shareholder and Talent Value
WuXi AppTec Co., Ltd, a global company that provides a broad portfolio of R&D and manufacturing services to enable companies in the pharmaceutical and ...
July 09, 2025 | News
WuXi XDC Completes Mechanical Build of Singapore Bioconjugate Manufacturing Hub
WuXi XDC Cayman Inc, a leading global Contract Research, Development and Manufacturing Organization (CRDMO) focused on the bioconjugate industry, announced...
July 02, 2025 | News
Thermo Fisher’s Integrated CDMO-CRO Model Cuts Drug Development Time by Up to 34 Months, Finds Tufts CSDD Study
Thermo Fisher Scientific Inc., the world leader in serving science, announced the findings of new research by the Tufts Center for the Study of Drug ...
June 17, 2025 | News
Most Read
- Top 25 Biotech & Biopharma Leaders in Sustainable Innovation, 2025
- China’s Biopharma Dealmaking Surges in H1 2025, Driven by Record Licensing and Oncology Focus
- Chikungunya in China: How a “Forgotten” Arbovirus Found the Perfect Storm
- How Innovation Gaps in Biopharma Raise New Safety Concerns
- Smart Implants and the Future of Musculoskeletal Injury Treatment
- How Ethical Gaps in Psychiatry Could Undermine Biopharma Progress
- The Evolving Landscape of Women’s Health Innovation in the Asia-Pacific
- Using NLP-Driven Decision Support in Emergency Health Assistance
- Taiwan Steps Into the Global Spotlight With a New Cancer Therapy
- The Role of Unique Device Identification (UDI) in Tracing Medical Device Safety
- The Importance of a Patient’s Mental Health During Clinical Trials
Bio Jobs
- The State of Biotech and Life Science Jobs in Asia Pacific – 2025
- Avantor’s New CEO Ligner Aims to Unlock Global Potential and Deliver Shareholder Value
- AstraZeneca Commits $50 Billion to U.S. Expansion by 2030 in Biggest-Ever Global Investment
- Thermo Fisher, SAMRC, and South Africa’s Department of Science and Innovation Launch CATIR to Nurture Next-Gen Scientists
- Cube Biotech Appoints Former Sartorius CEO Dr. Joachim Kreuzburg to Board of Directors
- FDA’s AI Transition Marks a Turning Point in Drug Review: Industry Faces Pressure to Adapt Amid 20% Workforce Cut
- WuXi XDC Completes Mechanical Build of Singapore Bioconjugate Manufacturing Hub
News
Editor Picks
